Biophysical techniques for ligand screening and drug design.

Abstract : Biophysical methods are currently involved in drug design in two ways: the qualitative detection of small molecule binding to a target (hit identification), and the quantitative determination of physical parameters associated to binding (hit-to-lead progression). In the first case, efforts have been made toward miniaturization, automation, and speed-up of the screening process allowing a higher throughput. In the second one, sophisticated applications have been developed to derive detailed relevant information. Preferably, several methods are used in combination to avoid bias and/or limitations associated with a single one, often together with computational methods. New developments should allow important systems overlooked so far to be studied: membrane proteins, intrinsically unstructured proteins, as well as in-cell studies.
Type de document :
Article dans une revue
Current Opinion in Pharmacology, Elsevier, 2009, 9 (5), pp.622-8. 〈10.1016/j.coph.2009.06.008〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00438664
Contributeur : Maité Peney <>
Soumis le : vendredi 4 décembre 2009 - 12:00:52
Dernière modification le : mercredi 14 mars 2018 - 16:48:13

Identifiants

Collections

Citation

Jean-Paul Renaud, Marc-André Delsuc. Biophysical techniques for ligand screening and drug design.. Current Opinion in Pharmacology, Elsevier, 2009, 9 (5), pp.622-8. 〈10.1016/j.coph.2009.06.008〉. 〈inserm-00438664〉

Partager

Métriques

Consultations de la notice

57